Literature DB >> 12794698

Medial temporal lobe dysgenesis in Muenke syndrome and hypochondroplasia.

Salvatore Grosso1, Maria Angela Farnetani, Rosario Berardi, Gabriella Bartalini, Marilisa Carpentieri, Paolo Galluzzi, Rosa Mostardini, Guido Morgese, Paolo Balestri.   

Abstract

Hypochondroplasia (HCH) and Muenke syndrome (MS) are caused by mutations on FGFR3 gene. FGFR3 is known to play a role in controlling nervous system development. We describe the clinical and neuroradiological findings of the first two patients, to our knowledge, affected by HCH and MS, respectively, in whom bilateral dysgenesis of the medial temporal lobe structures has been observed. In both patients diagnosis was confirmed by molecular analysis. They were mentally normal and showed similarities in early-onset temporal lobe-related seizures. In both patients EEG recorded bilateral temporal region discharges. MRI detected temporal lobe anomalies with inadequate differentiation between white and gray matter, defective gyri, and abnormally shaped hippocampus. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794698     DOI: 10.1002/ajmg.a.10171

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

Review 1.  Epilepsy in Muenke syndrome: FGFR3-related craniosynostosis.

Authors:  Nneamaka B Agochukwu; Benjamin D Solomon; Andrea L Gropman; Maximilian Muenke
Journal:  Pediatr Neurol       Date:  2012-11       Impact factor: 3.372

2.  A Korean family with the Muenke syndrome.

Authors:  Jae Eun Yu; Dong Ha Park; Soo Han Yoon
Journal:  J Korean Med Sci       Date:  2010-06-17       Impact factor: 2.153

3.  Muenke syndrome.

Authors:  G Sabatino; F Di Rocco; G Zampino; G Tamburrini; M Caldarelli; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2004-02-10       Impact factor: 1.475

4.  Temporal and occipital lobe features in children with hypochondroplasia/FGFR3 gene mutation.

Authors:  Cristina M Philpott; Elysa Widjaja; Charles Raybaud; Helen M Branson; Peter Kannu; Susan Blaser
Journal:  Pediatr Radiol       Date:  2013-05-07

Review 5.  Syndromic Craniosynostosis: Complexities of Clinical Care.

Authors:  Justine O'Hara; Federica Ruggiero; Louise Wilson; Greg James; Graeme Glass; Owase Jeelani; Juling Ong; Richard Bowman; Michelle Wyatt; Robert Evans; Martin Samuels; Richard Hayward; David J Dunaway
Journal:  Mol Syndromol       Date:  2019-01-16

6.  Brain and ventricular volume in patients with syndromic and complex craniosynostosis.

Authors:  T de Jong; B F M Rijken; M H Lequin; M L C van Veelen; I M J Mathijssen
Journal:  Childs Nerv Syst       Date:  2011-10-20       Impact factor: 1.475

7.  Incomplete Hippocampal Inversion: A Comprehensive MRI Study of Over 2000 Subjects.

Authors:  Claire Cury; Roberto Toro; Fanny Cohen; Clara Fischer; Amel Mhaya; Jorge Samper-González; Dominique Hasboun; Jean-François Mangin; Tobias Banaschewski; Arun L W Bokde; Uli Bromberg; Christian Buechel; Anna Cattrell; Patricia Conrod; Herta Flor; Juergen Gallinat; Hugh Garavan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Hervé Lemaitre; Jean-Luc Martinot; Frauke Nees; Marie-Laure Paillère Martinot; Dimitri P Orfanos; Tomas Paus; Luise Poustka; Michael N Smolka; Henrik Walter; Robert Whelan; Vincent Frouin; Gunter Schumann; Joan A Glaunès; Olivier Colliot
Journal:  Front Neuroanat       Date:  2015-12-22       Impact factor: 3.856

8.  Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.

Authors:  Romain Colle; Claire Cury; Marie Chupin; Eric Deflesselle; Patrick Hardy; Ghaidaa Nasser; Bruno Falissard; Denis Ducreux; Olivier Colliot; Emmanuelle Corruble
Journal:  Neuroimage Clin       Date:  2016-04-27       Impact factor: 4.881

9.  FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model.

Authors:  Maxence Cornille; Stéphanie Moriceau; Roman H Khonsari; Yann Heuzé; Léa Loisay; Valérie Boitez; Anne Morice; Eric Arnaud; Corinne Collet; Morad Bensidhoum; Nabil Kaci; Nathalie Boddaert; Giovanna Paternoster; Theresa Rauschendorfer; Sabine Werner; Suzanne L Mansour; Federico Di Rocco; Franck Oury; Laurence Legeai-Mallet
Journal:  J Exp Med       Date:  2022-03-07       Impact factor: 17.579

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.